Myocardial Contrast Echocardiography Evaluation of Tirofiban for the Myocardial Reperfusion of NSTEMI Patients Underwent PCI Treatment / 现代生物医学进展
Progress in Modern Biomedicine
; (24): 4731-4734, 2017.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-614775
Biblioteca responsável:
WPRO
ABSTRACT
Objective:
To explore the improvement effect of tirofiban on the myocardial reperfusion of non-ST segmant elevated myocardial infarction (NSTEMI) patients underwent percutaneous coronary intervention (PCI) treatment.Methods:
78 NSTEMI patients underwent PCI in our hospital from April 2012 to April 2015 were selected and divided into the observation group (n=38) and the control group (n=40) according to different drugs.Patients in the control group were given asprin,clopidogrel and heparin,while patients in the observation group were additionally given tirofiban.Then the myocardial contrast echocardiography (MCE) was taken to evluate the myocardial reperfusion.Results:
No statistical difference was found in the levels of A,β,A β,CK-MB and cTnⅠ before PCI between 2 groups.The levels of β,A β of observation group were obviously higher,CK-MB and cTnⅠ were obviously lower than those of the control group(P<0.05).The MACE rate of observation group was 2.63%,which was 5.00% in the control group,no significant difference was between two groups (P>0.05).Conclusion:
Tirofiban could obviously improve the myocardial reperfusion of NSTEMI patients underwent PCI with high safety.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Progress in Modern Biomedicine
Ano de publicação:
2017
Tipo de documento:
Artigo